Results 171 to 180 of about 219,955 (289)

Association of attention‐deficit/hyperactivity disorder and autism with inflammatory bowel disease activity

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives To estimate the effect of attention deficit hyperactivity disorder (ADHD) and autism on the disease activity of inflammatory bowel disease (IBD) in pediatric and young patients. Methods Patients diagnosed with IBD between the ages of 6 and 24 years were identified in Danish nationwide registries 1996–2022.
Sabine Jansson   +7 more
wiley   +1 more source

Solitary Rectal Ulcer Syndrome Mimicking Ulcerative Colitis: A Case Report. [PDF]

open access: yesCureus
Bouziane A   +9 more
europepmc   +1 more source

Appropriate screening strategy and timely referral in suspected pediatric inflammatory bowel disease: Impact on diagnostic delay and severity at presentation

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Pediatric‐onset inflammatory bowel disease (pIBD) often presents with nonspecific symptoms, contributing to diagnostic delay (DD) and increased morbidity. Despite the importance of referral quality, diagnostic pathways in pIBD have rarely been evaluated.
Francesca Borgiani   +4 more
wiley   +1 more source

Disability in pediatric inflammatory bowel diseases: A systematic review and a single center experience

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Toward development of a pediatric IBD disability index (PIDI), we aimed to review the literature on disability in pediatric inflammatory bowel disease (PIBD) and to estimate disability rates in a pediatric inception cohort. Methods A systematic review identified studies reporting disability in PIBD and in adult randomized controlled
Reut Rappaport   +13 more
wiley   +1 more source

Chronic conditions associated with paediatric onset inflammatory bowel diseases: A population‐based study

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objective Several conditions are associated with inflammatory bowel disease (IBD), including immune‐mediated inflammatory diseases (IMIDs), extraintestinal manifestations (EIMs), and psychiatric disorders. This study aimed to describe at population‐level the comorbidities and their relative burden in paediatric‐onset IBD (pIBD).
Nicolas Richard   +480 more
wiley   +1 more source

Fecal microRNA signatures as non‐invasive diagnostic and prognostic markers of pediatric inflammatory bowel diseases

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives The identification of novel noninvasive diagnostic and prognostic biomarkers for pediatric inflammatory bowel disease (PIBD), including pediatric Crohn's disease (pCD) and ulcerative colitis (pUC), is crucial for improving therapeutic outcomes.
Tereza Pinkasova   +11 more
wiley   +1 more source

Raising the bar: Utilizing quality improvement tools to increase compliance with clinical care guidelines in inflammatory bowel disease patients

open access: yesJPGN Reports, EarlyView.
Abstract Patients admitted for inflammatory bowel disease (IBD) are often managed by rotating teams of care providers during their hospital stay. This can lead to potential variability in the care they receive. Our team developed a scoring system of six key high‐quality care components called the standardized IBD care index (SICI) to standardize care ...
Amir Jazayeri   +4 more
wiley   +1 more source

The safe and effective use of tofacitinib and ustekinumab combination therapy in infantile onset inflammatory bowel disease

open access: yesJPGN Reports, EarlyView.
Abstract Infantile‐onset inflammatory bowel disease (IOIBD) is a rare and severe subset of very‐early‐onset IBD, often associated with immune dysregulation and poor response to conventional therapies. Data regarding the use of Janus kinase inhibitors (JAKI) in this population is limited.
Smridhi Mahajan   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy